CLASS-HF: Consistently Assess Signs and Symptoms of Heart Failure

CLASS-HF: Consistently Assess Signs and Symptoms of Heart Failure

Brief description of study

The purpose of this study is to examine the reliability and validity of the New York Heart Association (NYHA) Classification Guide that was developed to assist providers in appropriately assigning a functional class to their patients with heart failure. We will be evaluating the NYHA Classification guide against the 6-minute walk test (6MWT), which is viewed as the standard. A total of 102 patients will be participating in this study from 3 clinical sites.

Detailed description of study

Once the participant has been consented, the provider will complete functional classification using the NYHA Classification Guide and provide it to the study coordinator. The study staff performing the 6MWT and the patient will be blinded from the results until after the completion of the walk test. The study staff will collect study data and then conduct the 6MWT. Once the 6MWT is complete, the participant's study involvement ends.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Heart failure
  • Age: Between 18 Years - 90 Years
  • Gender: All

Inclusion
  • Between the ages of 18 and 90
  • Documented confirmed Heart Failure diagnosis
  • Under the care of a Cardiologist and/or Advanced Practice Provider in Cardiology
  • Able to walk without assistance
Exclusion
  • Diagnosed with myocardial infarction, coronary artery bypass graft (CABG), angioplasty or stent in the previous 30-days
  •  Unstable angina in the previous 30 days
  • Active endocarditis
  • Acute myocarditis or pericarditis
  • Symptomatic severe aortic stenosis
  • Uncontrolled hypertension with systolic blood pressure readings > 180 mmHg or diastolic pressure readings > 100 mmHg

Updated on 26 Mar 2024. Study ID: 2023-8
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center